Health profile of preterm males with duchenne muscular dystrophy
Soim, A., Wallace, B., Whitehead, N., Smith, M. G., Mann, J. R., Thomas, S., Ciafaloni, E., Muscular Dystrophy Surveillance, & Tracking Res Network MD STARnet (2021). Health profile of preterm males with duchenne muscular dystrophy. Journal of Child Neurology, 36(12), 1095-1102. Article 08830738211047019. Advance online publication. https://doi.org/10.1177/08830738211047019
In this retrospective cohort study, we characterize the health profile of preterm males with Duchenne muscular dystrophy. Major clinical milestones (ambulation cessation, assisted ventilation use, and onset of left ventricular dysfunction) and corticosteroids use in males with Duchenne muscular dystrophy identified through a population-based surveillance system were analyzed using Kaplan-Meier survival curves and Cox proportional hazards modeling. The adjusted risk of receiving any respiratory intervention among preterm males with Duchenne muscular dystrophy was 87% higher than among the corresponding full-term males with Duchenne muscular dystrophy. The adjusted risks for ambulation cessation and left ventricular dysfunction were modestly elevated among preterm compared to full-term males, but the 95% confidence intervals contained the null. No difference in the start of corticosteroid use between preterm and full-term Duchenne muscular dystrophy males was observed. Overall, the disease course seems to be similar between preterm and full-term males with Duchenne muscular dystrophy; however, pulmonary function seems to be affected earlier among preterm males with Duchenne muscular dystrophy.